Sign In
Buy KALA
$3.54
-0.0700 (-1.94%)
At Close: Jun 22, 2026
Acorn Energy: Incremental Revenue All Drops To Bottom Line (OTCMKTS:ACFN)
02:48pm, Monday, 21'st Sep 2020
ACFN trades at 3.2x ARR and 3x Gross Profit, multiples normally for IoT companies with half the margins. FCF has hit an inflection due to fixed expense base.
Kemenperin rancang aturan teknis penetapan kawasan peruntukan industri
08:59am, Thursday, 27'th Aug 2020
Kementerian Perindustrian (Kemenperin) menyusun rancangan peraturan tentang kriteria teknis penetapan kawasan peruntukan industri (KPI), yang nantinya ...
Led by Asia-Pacific, global hotel industry makes monthly strides
03:48pm, Wednesday, 26'th Aug 2020
According to July profit and loss data, the global regions continue to accrue negative months of profitability, with Asia-Pacific the exception, after two | eTurboNews | Trends | Travel News | Hospita
Breaking clean
12:00am, Sunday, 23'rd Aug 2020
Breaking Bad was a seminal piece of literature. One might say it even marked a small turning point in the history of storytelling.
HUYA's (HUYA) CEO Rongjie Dong on Q2 2020 Results - Earnings Call Transcript
01:40am, Wednesday, 12'th Aug 2020
HUYA, Inc. (NYSE:HUYA) Q2 2020 Earnings Conference Call August 11, 2020 7:00 AM ET Company Participants Dana Cheng – Investor Relations Rongjie Dong – Chief Executive Officer Catherine Liu – Chi
Kala Pharmaceuticals Inc (NASDAQ:KALA) Receives Consensus Recommendation of “Buy” from Analysts
11:24pm, Sunday, 09'th Aug 2020
Shares of Kala Pharmaceuticals Inc (NASDAQ:KALA) have received a consensus recommendation of “Buy” from the nine ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst
Wedbush Keeps a Buy Rating on Kala Pharmaceuticals (KALA) - Markets
01:35pm, Sunday, 09'th Aug 2020
Wedbush analyst Liana Moussatos maintained a Buy rating on Kala Pharmaceuticals (KALA – Research Report) on August 7 and set
Did Hedge Funds Make The Right Call On Kala Pharmaceuticals, Inc. (KALA)?
01:26pm, Friday, 07'th Aug 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Kala Pharmaceuticals (KALA) Reports Q2 Loss, Tops Revenue Estimates
01:15pm, Thursday, 06'th Aug 2020
Kala Pharma (KALA) delivered earnings and revenue surprises of 0.00% and 9.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
11:00am, Thursday, 06'th Aug 2020
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported financ
Kala Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
12:00pm, Tuesday, 04'th Aug 2020
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that
Council Post: 16 Custom KPIs To Better Understand Your Marketing Numbers
12:00am, Tuesday, 04'th Aug 2020
Businesses that want to innovate and push boundaries need to develop their own custom KPIs that can help them dive into their marketing and communication statistics like standard ones don't.
No festive joy, it’s pedal till you puke for Tokyo-bound cyclists
12:00am, Monday, 03'rd Aug 2020
PETALING JAYA: There’s no living it up for Malaysia’s top cyclists Azizulhasni Awang and Mohd Shah Firdaus Sahrom.
Kala Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call
08:01pm, Thursday, 30'th Jul 2020
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that
How Much is Kala Pharmaceuticals' (NASDAQ:KALA) CEO Getting Paid?
05:01pm, Tuesday, 28'th Jul 2020
Mark Iwicki became the CEO of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) in 2015, and we think it's a good time to look...
